SCHEMBL1127990

SCHEMBL1127990

CCC(Br)CCCOc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.54
TDP1 Q9NUW8 1/20 0.53
LTA4H P09960 2/20 0.52
HTR1B P28222 2/20 0.47
CHRNB2 P17787 2/20 0.46
CHRNB4 P30926 2/20 0.46
CHRNA3 P32297 2/20 0.46
CHRNA7 P36544 2/20 0.46
CHRNA4 P43681 2/20 0.46
ALOX5 P09917 1/20 0.44
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
DRD2 P14416 2/20 0.44
DRD3 P35462 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27696496 0.90 LSS (0.53) TDP1LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL3791089 0.87 LTA4H (0.59) KCNA3TDP1LTA4HHTR1BCHRNB2
SCHEMBL7212160 0.87 LTA4H (0.55) KCNA3TDP1LTA4HHTR1BCHRNB2
SCHEMBL31474674 0.84 LTA4H (0.57) KCNA3TDP1LTA4HALOX5PPARG
SCHEMBL9145902 0.84 LTA4H (0.57) KCNA3TDP1LTA4HALOX5PPARG
SCHEMBL29173237 0.81 KCNA3 (0.58) KCNA3TDP1LTA4HHTR1BCHRNB2
SCHEMBL18174179 0.80 KCNA3 (0.62) KCNA3TDP1LTA4HHTR1BDRD2
SCHEMBL22692744 0.79 KCNA3 (0.56) KCNA3TDP1LTA4HHTR1BCHRNB2
SCHEMBL17009054 0.79 LMNA (0.53) KCNA3LTA4HCHRNB2CHRNB4CHRNA3
SCHEMBL6302467 0.78 ALOX5 (0.59) LTA4HCHRNB2CHRNB4CHRNA3CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140034623-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2014-02-06 US disclosed
EP-2283021-B1 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2014-01-08 EP disclosed
US-8586745-B2 Switchable special effect substances BASF SE (DE) 2013-11-19 US disclosed
US-20110060113-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2011-03-10 US disclosed
EP-2283021-A2 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2011-02-16 EP disclosed
WO-2009141288-A2 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2009-11-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110060113-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES PPARG, PTGER4, NR2E3 KCNA3 2229/4885TDP1 3584/4885LTA4H 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.